• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干预措施治疗蠕形螨性睑缘炎及其疗效的系统评价和 Meta 分析。

Interventions for Demodex blepharitis and their effectiveness: A systematic review and meta-analysis.

机构信息

Department of Ophthalmology, School of Medicine, Universidad Nacional de Colombia, Bogotá, Colombia; Basic and Clinic Ophthalmology Research Group, School of Medicine, Universidad Nacional de Colombia, Bogotá, Colombia.

Department of Ophthalmology, School of Medicine, Universidad Nacional de Colombia, Bogotá, Colombia; Basic and Clinic Ophthalmology Research Group, School of Medicine, Universidad Nacional de Colombia, Bogotá, Colombia.

出版信息

Cont Lens Anterior Eye. 2021 Dec;44(6):101453. doi: 10.1016/j.clae.2021.101453. Epub 2021 May 7.

DOI:10.1016/j.clae.2021.101453
PMID:33972176
Abstract

PURPOSE

A systematic review and meta-analysis was performed to evaluate the effectiveness of interventions in the treatment ofDemodex blepharitis in adult patients.

METHODS

A systematic review and meta-analysis of studies reporting the efficacy of treatments forDemodex blepharitis in the main databases (PubMed / Scopus / Cochrane / EMBASE / Science Direct / WOS / Scielo / Google Scholar / metaRegister of Controlled Trials / ClinicalTrials.gov/ WHO ICTRP) until November 24, 2020 was performed according to the PRISMA statement for meta-analysis.

RESULTS

Overall, 18 studies were included for 29 different interventions in 1195 participants with 1574 eyes that were positive for Demodex Spp. Demodex counts, total eradication, clinical improvement, Ocular Surface Disease Index, Tear Break-Up Time, cylindrical dandruff, Schirmer test, osmolarity and adverse reactions were analysed, and stratified sub-analyses conducted. The overall effects for Demodex count (mean difference), total eradication (risk ratio) and adverse reactions (risk difference) were -2.07 (95 % CI -3.99 to -0.15) p = 0.03, 1.84 (95 % CI 1.27-2.66) p = 0.001 and 0.24 (95 % CI 0.08 to 0.41) p = 0.005, respectively. The most frequent interventions evaluated in the included studies were tea tree oil (TTO) and its derivatives, such as terpinen 4-ol.

CONCLUSION

Multiple therapeutic choices were evaluated in this meta-analysis. Pharmacological interventions were superior to non-pharmacological (mechanical, thermal and pulsed light) interventions. It was not possible to establish significant differences between TTO and non-TTO-derived treatments. Adverse reactions were more frequent in TTO-derived treatments, however all were mild. It is necessary to execute studies with longer follow-up times to determine whether re-infestation occurs after the administration of different treatments.

摘要

目的

系统评价和荟萃分析评估了干预措施治疗成人蠕形螨性睑缘炎的疗效。

方法

根据荟萃分析的 PRISMA 声明,对主要数据库(PubMed / Scopus / Cochrane / EMBASE / Science Direct / WOS / Scielo / Google Scholar / metaRegister of Controlled Trials / ClinicalTrials.gov/ WHO ICTRP)中截至 2020 年 11 月 24 日报告治疗蠕形螨性睑缘炎疗效的研究进行了系统评价和荟萃分析。

结果

共有 18 项研究纳入 29 种不同干预措施,共 1195 名参与者,1574 只眼被诊断为蠕形螨属阳性。分析了蠕形螨计数、总清除率、临床改善、眼表面疾病指数、泪膜破裂时间、圆柱状头皮屑、泪液分泌试验、渗透压和不良反应,并进行了分层亚分析。蠕形螨计数(均数差)、总清除率(风险比)和不良反应(风险差)的总体效应分别为-2.07(95%CI-3.99 至-0.15),p=0.03、1.84(95%CI1.27-2.66),p=0.001 和 0.24(95%CI0.08 至 0.41),p=0.005。纳入研究中评估最多的干预措施是茶树油(TTO)及其衍生物,如萜品-4-醇。

结论

本荟萃分析评估了多种治疗选择。与非药物(机械、热和脉冲光)干预相比,药物干预更有效。TTO 和非 TTO 衍生治疗之间的差异没有统计学意义。TTO 衍生治疗的不良反应更为常见,但均为轻度。需要进行随访时间更长的研究,以确定在使用不同治疗后是否会再次感染。

相似文献

1
Interventions for Demodex blepharitis and their effectiveness: A systematic review and meta-analysis.干预措施治疗蠕形螨性睑缘炎及其疗效的系统评价和 Meta 分析。
Cont Lens Anterior Eye. 2021 Dec;44(6):101453. doi: 10.1016/j.clae.2021.101453. Epub 2021 May 7.
2
Tea tree oil for Demodex blepharitis.茶树油治疗睑缘蠕形螨睑缘炎。
Cochrane Database Syst Rev. 2020 Jun 20;6(6):CD013333. doi: 10.1002/14651858.CD013333.pub2.
3
Efficacy of cyclic therapy with terpinen-4-ol in Demodex blepharitis : Is treatment possible by considering Demodex's life cycle?萜品烯-4-醇治疗睑缘蠕形螨病的疗效:是否可以通过考虑蠕形螨的生命周期来进行治疗?
Eur J Ophthalmol. 2021 May;31(3):1361-1366. doi: 10.1177/1120672120919085. Epub 2020 Apr 24.
4
Evaluation of the Efficacy of Tea Tree Oil On the Density of Demodex Mites (Acari: Demodicidae) and Ocular Symptoms In Patients With Demodectic Blepharitis.茶树油对睑缘炎患者蠕形螨(蜱螨亚纲:蠕形螨科)密度及眼部症状疗效的评估
J Parasitol. 2018 Oct;104(5):473-478. doi: 10.1645/18-46. Epub 2018 Jul 26.
5
Demodex Blepharitis: An Analysis of Nine Patients.睑缘蠕形螨病:九例患者分析。
Korean J Parasitol. 2022 Dec;60(6):429-432. doi: 10.3347/kjp.2022.60.6.429. Epub 2022 Dec 22.
6
Efficacy and Safety of Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: A Meta-Analysis of Randomized Controlled Trials.Lotilaner 眼科溶液 0.25% 治疗蠕形螨性睑缘炎的疗效和安全性:一项随机对照试验的荟萃分析。
Cont Lens Anterior Eye. 2024 Jun;47(3):102148. doi: 10.1016/j.clae.2024.102148. Epub 2024 Mar 21.
7
Efficacy and Safety of Lotilaner Ophthalmic Solution (0.25%) for the Treatment of Demodex Blepharitis: A GRADE Assessed Systematic Review and Meta-Analysis of Observational & Experimental Studies.洛替拉奈滴眼液(0.25%)治疗睑缘蠕形螨睑缘炎的疗效和安全性:基于GRADE评估的观察性与实验性研究的系统评价和荟萃分析
Am J Ophthalmol. 2024 Aug;264:8-16. doi: 10.1016/j.ajo.2024.03.019. Epub 2024 Mar 19.
8
Efficacy of treatments for Demodex blepharitis: A systematic review and meta-analysis.治疗蠕形螨性睑缘炎的疗效:系统评价和荟萃分析。
Ocul Surf. 2019 Oct;17(4):655-669. doi: 10.1016/j.jtos.2019.06.004. Epub 2019 Jun 20.
9
Update on the Management of Demodex Blepharitis.关于睑缘蠕形螨病的治疗进展。
Cornea. 2022 Aug 1;41(8):934-939. doi: 10.1097/ICO.0000000000002911. Epub 2021 Nov 3.
10
Palpebral and facial skin infestation by Demodex folliculorum.眼睑和面部皮肤感染毛囊蠕形螨。
Cont Lens Anterior Eye. 2020 Apr;43(2):115-122. doi: 10.1016/j.clae.2019.09.001. Epub 2019 Sep 25.

引用本文的文献

1
Intense Pulsed Light Combined with Low Level Blue and Red Light Therapy for -Associated Blepharitis.强脉冲光联合低强度蓝光和红光治疗睑缘炎
Clin Ophthalmol. 2025 Aug 7;19:2575-2585. doi: 10.2147/OPTH.S521989. eCollection 2025.
2
..
Diagnostics (Basel). 2025 Jun 15;15(12):1520. doi: 10.3390/diagnostics15121520.
3
Could ocular demodicosis be a risk factor for punctal stenosis, dry eye, and blepharitis?眼部蠕形螨病会是泪小点狭窄、干眼和睑缘炎的一个风险因素吗?
Indian J Ophthalmol. 2025 Apr 1;73(4):603-609. doi: 10.4103/IJO.IJO_2187_24. Epub 2025 Mar 27.
4
Preferred practice guidelines and narrative review on infectious keratitis in ocular surface diseases.眼表疾病中感染性角膜炎的首选实践指南及叙述性综述
Indian J Ophthalmol. 2025 Apr 1;73(4):508-515. doi: 10.4103/IJO.IJO_1917_24. Epub 2025 Mar 27.
5
Demodex and the eye - A review.蠕形螨与眼睛——综述
Indian J Ophthalmol. 2025 Jan 1;73(1):10-18. doi: 10.4103/IJO.IJO_1591_24. Epub 2024 Dec 23.
6
Terpinen-4-ol Improves Lipopolysaccharide-Induced Macrophage Inflammation by Regulating Glutamine Metabolism.松油烯-4-醇通过调节谷氨酰胺代谢改善脂多糖诱导的巨噬细胞炎症。
Foods. 2024 Jun 12;13(12):1842. doi: 10.3390/foods13121842.
7
The impact of Demodex blepharitis on patient symptoms and daily life.睑缘蠕形螨病对患者症状和日常生活的影响。
Optom Vis Sci. 2024 Mar 1;101(3):151-156. doi: 10.1097/OPX.0000000000002111. Epub 2024 Feb 7.
8
Chicago sky blue gel for better visualization of in patients with blepharitis.芝加哥天蓝色凝胶可改善 患者 睑缘炎的可视化效果。
PeerJ. 2023 Nov 17;11:e16378. doi: 10.7717/peerj.16378. eCollection 2023.
9
Delphi Panel Consensus Regarding Current Clinical Practice Management Options for .关于……当前临床实践管理选项的德尔菲专家小组共识
Clin Ophthalmol. 2023 Feb 27;17:667-679. doi: 10.2147/OPTH.S399989. eCollection 2023.
10
Antiparasitic Activity of Tea Tree Oil (TTO) and Its Components against Medically Important Ectoparasites: A Systematic Review.茶树油(TTO)及其成分对重要医学外寄生虫的抗寄生虫活性:系统评价
Pharmaceutics. 2022 Jul 29;14(8):1587. doi: 10.3390/pharmaceutics14081587.